ArticlePNAS nexus2026
Identifying common G protein-coupled receptor interacting proteins independent of heterotrimeric G proteins and β-arrestins.
Article in PNAS nexus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The canonical paradigm of G protein-coupled receptor (GPCR) signaling recognizes G proteins, β-arrestins, and GPCR kinases as the primary transducers that shape GPCR signaling. However, multiple studies have demonstrated that other interacting proteins regulate GPCR function in addition to these pathways, termed GPCR-interacting proteins (GIPs). The atypical chemokine receptor 3 (ACKR3) does not couple to G proteins, and β-arrestins have been shown to be dispensable for many of its functions. Here, we employed proximity labeling to identify proteins that interact with ACKR3 in cells devoid of β-arrestins. Among conserved proteins from our and several similar GPCR-based proximity labeling experiments, we discovered components of the endocytic machinery and other putative interacting proteins that can interact with GPCRs independent of G proteins and β-arrestins. Notably, we discovered that the bone morphogenetic protein 2-inducible kinase (BMP2K) interacts with ACKR3 in a phosphorylation-dependent manner that is distinct from its interaction with β-arrestin. We demonstrate BMP2K's ability to interact with many different GPCRs with varying dependency on β-arrestin. Using molecular dynamic simulations, we discovered an asparagine-proline-phenylephrine (NPF)-binding motif in BMP2K critical for its interaction with GPCRs and determined that this motif is conserved across many other GIPs. These findings reveal an expanded network of GIPs that interact with GPCRs independent of G proteins and β-arrestins, highlighting alternative mechanisms by which GPCR signaling may be transduced beyond canonical paradigms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.